PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.5460
-0.0441 (-7.47%)
At close: Aug 10, 2026, 4:00 PM EDT
0.5512
+0.0052 (0.95%)
After-hours: Aug 10, 2026, 7:31 PM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $5.86 million as of August 10, 2026. Its market cap has increased by 2.84% in one year.
Market Cap
5.86M
Enterprise Value
-31.22M
1-Year Change
2.84%
Ranking
Category
Stock Price
$0.55
ChartMarket Cap Chart
Since August 10, 2021, PharmaCyte Biotech's market cap has increased from $4.90M to $5.86M, an increase of 19.63%. That is a compound annual growth rate of 3.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 5.86M | -19.70% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 957.14% |
| Aug 10, 2021 | 4.90M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.89M |
| Imunon | 6.77M |
| Acurx Pharmaceuticals | 6.62M |
| Alzamend Neuro | 6.56M |
| FibroBiologics | 6.50M |
| CollPlant Biotechnologies | 6.41M |
| AIM ImmunoTech | 6.30M |
| NuCana | 6.12M |